S&P 500
(-0.10%) 5 464.00 points
Dow Jones
(-0.09%) 39 076 points
Nasdaq
(0.15%) 17 744 points
Oil
(-0.74%) $80.23
Gas
(-4.32%) $2.64
Gold
(-0.84%) $2 311.30
Silver
(0.01%) $28.87
Platinum
(2.32%) $1 009.30
USD/EUR
(0.30%) $0.936
USD/NOK
(0.73%) $10.68
USD/GBP
(0.49%) $0.792
USD/RUB
(-0.27%) $87.25

Realtime updates for Pluristem Therapeutics [PSTI]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated26 Jul 2022 @ 00:00

-2.91% $ 1.000

Live Chart Being Loaded With Signals

Commentary (26 Jul 2022 @ 00:00):

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders...

Stats
Today's Volume 170 627
Average Volume 0
Market Cap 40.85M
EPS $-0.310 ( Q3 | 2022-05-09 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.684
(Sector) 42.63
(Industry) 24.32
ATR14 $0.104 (10.40%)
AADI -3.53%
ABCL 1.83%
ABCM 0.04%
ABEO -2.13%
ABIO -1.69%
ABOS 0.00%
ABSI 1.87%
ABUS -2.13%
ABVX -2.03%
ACAD -0.58%
ACER -17.95%
ACET -5.10%
ACGN 1.29%
ACHL -2.20%
ACHV -1.29%
ACIU -1.50%
ACLX 0.25%
ACRV -5.30%
ACST -3.58%
ACXP 1.38%
ADAG 4.64%
ADAP -3.93%
ADGI 0.87%
ADIL 0.54%
ADMA -2.77%
ADPT 0.30%
ADTX -3.47%
ADVM -3.40%
ADXN -1.60%
AEON -3.74%
AEZS -2.49%
AFMD -0.61%
AGEN -3.03%
AGIO -2.48%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -1.95%
AKRO -2.60%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -1.15%
ALGS -2.30%
ALKS -0.23%
ALLK -8.90%
ALLO -4.58%
ALLR -3.37%
ALNA 3.16%
ALNY 2.42%
ALPN 0.02%
ALPX 0.00%
ALRN 0.33%
ALT -9.59%
ALVR 2.27%
ALXN 0.00%
ALXO -11.19%
ALZN 1.97%
AMRN -0.72%
AMTI -3.13%
ANAB 1.05%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -1.75%
ANPC -3.15%
APGE -1.05%
APGN 8.48%
APGNW 30.65%
APLM -6.49%
APLS 0.50%
APLT -3.61%
APM -2.94%
APOP 0.38%
APRE 0.61%
APTO 6.30%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -4.38%
ARDS -14.23%
ARDX -0.50%
ARGX -1.09%
ARNA 0.00%
ARPO -0.90%
ARQT -1.30%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.27%
ARWR -1.67%
ASLN -5.07%
ASMB -5.83%
ASND -1.45%
ATAI -1.48%
ATHA 5.48%
ATHE 0.55%
ATHX -33.50%
ATNF 0.99%
ATOS 0.97%
ATRA -2.83%
ATXI 1.93%
ATXS -0.67%
AUPH -0.90%
AURA 1.17%
AUTL -2.01%
AVBP -4.23%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -4.14%
AVTX -1.25%
AVXL -2.96%
AXLA 0.00%
AXSM -1.56%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 2.06%
BCAB 3.92%
BCDA -2.73%
BCDAW -41.77%
BCEL 0.00%
BCLI 5.82%
BCRX 1.07%
BCTX 8.16%
BCTXW -17.41%
BCYC 1.35%
BDRX -4.94%
BDTX -0.85%
BEAM 0.82%
BFRA -2.91%
BGNE -2.99%
BIOR -5.14%
BIVI 4.67%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.62%
BLU 0.03%
BLUE -0.25%
BMEA -11.52%
BMRN 0.52%
BNOX 4.61%
BNTC -0.42%
BNTX -1.87%
BOLD -8.47%
BOLT 0.72%
BPMC -0.99%
BPTH 1.42%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 25.39%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 1.04%
CADL -1.31%
CALA 0.00%
CALC -1.77%
CALT -1.14%
CAPR -2.80%
CARA 0.72%
CARM 10.50%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.39%
CCCC -5.20%
CCXI 0.00%
CDAK 0.00%
CDIO -2.20%
CDIOW 24.00%
CDMO -2.96%
CDMOP 0.04%
CDT -12.35%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.41%
CDXS 7.24%
CELC -4.55%
CELU -1.97%
CELUW 11.80%
CERC -1.68%
CERE -1.01%
CERO -4.45%
CEROW -20.21%
CFRX -27.95%
CGEM -2.34%
CGEN -3.33%
CGON -0.83%
CGTX -4.54%
CHMA -6.00%
CHRS 0.34%
CINC 0.00%
CING -0.23%
CINGW 34.95%
CKPT -3.35%
CLBS -16.75%
CLDX -2.02%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.41%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 2.42%
CMPI 0.00%
CMPX -5.73%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.04%
CNCE 0.00%
CNSP -37.32%
CNST 0.00%
CNTA -0.67%
CNTB 0.00%
CNTX -6.85%
COCP -2.00%
COEPW 32.45%
COGT -2.17%
CORT 2.02%
COYA -1.46%
CPRX -1.12%
CRBP -3.10%
CRBU -4.83%
CRDF -0.89%
CRGX 0.47%
CRIS -0.38%
CRNX -5.88%
CRSP 1.21%
CRTX 2.63%
CRVO -4.08%
CRVS 1.82%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -2.89%
CTNM -1.35%
CTXR 2.86%
CUE 3.81%
CVAC -2.54%
CVKD 0.11%
CWBR 2.80%
CYAD -12.96%
CYCC 10.09%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -1.77%
CYTO -1.82%
DARE 6.41%
DAWN 0.41%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 26.94%
DNLI -1.39%
DNTH -9.16%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.96%
DTIL 0.56%
DYAI 10.32%
EARS -1.77%
EDIT -2.42%
EDSA 3.19%
EFTR 6.82%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.56%
ELEV -5.81%
ELOX 7.69%
ELTX -0.88%
ELVN -4.40%
ELYM 2.30%
ENGN -3.64%
ENGNW 0.00%
ENLV 2.54%
ENOB 1.79%
ENSC 5.21%
ENTA -0.57%
ENTO -2.47%
ENTX 2.08%
ENVB 1.45%
EPIX -0.31%
EPRX -2.97%
EPZM 0.00%
EQ 0.32%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.20%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -0.51%
ETON 2.13%
ETTX 0.00%
EVAX -2.14%
EVGN 3.97%
EVLO 0.00%
EWTX 0.12%
EXAI -0.76%
EXEL -0.20%
EYEG -0.69%
EYEN 0.43%
EYPT 0.68%
FATE -7.40%
FBIO 0.89%
FBIOP 0.92%
FBLG -15.40%
FBRX -0.04%
FDMT -3.77%
FENC -1.29%
FGEN -5.15%
FHTX 1.72%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.48%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.09%
FULC -3.29%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.73%
GANX -2.31%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.09%
GHRS -2.16%
GLMD -4.96%
GLPG -2.26%
GLSI 1.69%
GLTO -0.57%
GLUE -2.51%
GLYC -9.52%
GMAB -0.58%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.91%
GNLX 1.11%
GNPX 0.98%
GNTA 3.94%
GOSS -12.01%
GOVX 5.00%
GOVXW -49.04%
GPCR -6.78%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.36%
GRTX 2.57%
GTHX 1.14%
GUTS -5.54%
GXGXW 41.67%
GYRE -6.02%
HALO -1.49%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX 0.08%
HOOK -0.76%
HOTH -2.70%
HOWL -2.77%
HRMY 0.37%
HRTX 3.77%
HSTO 0.00%
HUMA 0.61%
HUMAW -0.01%
IBRX -3.92%
ICCC 0.22%
ICPT 0.21%
ICU 17.27%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.72%
IFRX -1.85%
IGMS -0.44%
IKNA 1.19%
IKT 1.42%
IMAB -0.29%
IMCR -2.99%
IMGN 0.02%
IMGO 0.00%
IMMP 5.70%
IMMX -7.33%
IMNM -1.82%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX -0.35%
IMTX -1.67%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.70%
INAB -0.01%
INBX 0.43%
INCY -0.94%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM 3.36%
INMB 1.95%
INO -2.02%
INSM -1.23%
INTS -2.75%
INVA 0.34%
INZY 1.03%
IOBT -11.02%
IONS 0.26%
IOVA -2.01%
IPA 2.50%
IPHA 5.58%
IPSC -1.95%
IRON -2.43%
ISEE 0.38%
ITOS -1.90%
ITRM 1.67%
IVA 6.96%
IVVD -2.07%
JAGX 1.45%
JANX -4.05%
JAZZ -0.69%
JNCE 0.00%
JSPR -6.20%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -1.39%
KDNY 0.22%
KMPH -0.34%
KNSA -2.64%
KNTE -0.38%
KOD -6.72%
KPRX 0.96%
KPTI -2.30%
KRBP -10.00%
KRON 1.05%
KROS -1.38%
KRRO -8.23%
KRTX 0.03%
KRYS -1.16%
KTRA 16.06%
KTTA 8.16%
KTTAW 0.92%
KURA -1.51%
KYMR -2.60%
KYTX -4.13%
KZIA 2.65%
KZR -0.93%
LABP 0.57%
LBPH -2.11%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.91%
LENZ -3.84%
LEXX 2.31%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.80%
LIAN -8.28%
LIFE 2.70%
LIPO -11.13%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.48%
LPCN -2.95%
LPTX -1.65%
LQDA -0.90%
LRMR -2.20%
LSTA -4.06%
LTRN 1.37%
LUMO -1.32%
LVTX -1.03%
LXEO -4.21%
LXRX -2.06%
LYEL -33.41%
LYRA 0.93%
MACK 0.10%
MBIO -11.30%
MBRX -2.57%
MCRB 2.43%
MDGL -3.53%
MDNA -13.16%
MDWD 0.03%
MDXG -2.58%
MEIP -0.13%
MESO -2.08%
MGNX -2.92%
MGTA -7.74%
MGTX -3.56%
MGX -4.83%
MIRM -1.60%
MIRO 0.59%
MIST 0.77%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.89%
MLYS -6.49%
MNKD -0.96%
MNMD 0.50%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.20%
MORF -2.75%
MREO -3.71%
MRKR 2.68%
MRNA -5.17%
MRNS -4.06%
MRSN -1.90%
MRTX -0.17%
MRUS 0.25%
MRVI -1.89%
MTCR -1.29%
MTEM 4.95%
MTP -18.50%
MURA -1.24%
MYMD 5.41%
NAMS 1.88%
NAMSW 0.43%
NAUT 1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.82%
NERV -0.63%
NEXI 4.04%
NGM -1.28%
NGNE -1.93%
NKGN 9.32%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.89%
NLSP 7.65%
NLSPW 26.67%
NMRA -3.20%
NMTR -42.97%
NOVN -24.84%
NRBO 12.63%
NRIX -0.05%
NRSN -5.18%
NRSNW 0.00%
NRXP -5.20%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -5.54%
NTRBW -31.07%
NUVL -1.53%
NVAX -2.43%
NVCT 2.39%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.26%
OABIW -10.06%
OBIO -3.36%
OBSV 0.00%
OCEA -0.70%
OCGN 3.81%
OCS -1.00%
OCUL -1.83%
OCUP 1.31%
ODT -4.27%
OKYO 1.51%
OLMA -5.88%
OMER -0.51%
OMGA 5.39%
ONCO 4.96%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY -0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 2.06%
ORGS 0.65%
ORIC -3.41%
ORMP 20.98%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.29%
OVID -1.43%
OYST 0.00%
PALI 2.58%
PASG -1.30%
PBLA -7.50%
PBM -4.89%
PBYI 1.35%
PCSA 0.00%
PCVX -0.34%
PDSB -3.52%
PEPG 2.56%
PGEN -2.99%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -0.85%
PHIOW 36.47%
PHVS -6.81%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.20%
PLUR 7.49%
PMN 0.72%
PMVP 0.00%
PNT 0.16%
PPBT -10.64%
PRAX 1.04%
PRDS 0.93%
PRLD -3.17%
PROG -3.47%
PROK -0.45%
PRQR -0.01%
PRTA -2.26%
PRTC 0.49%
PRTG -0.54%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -6.18%
PSTX -0.58%
PTCT -0.77%
PTE -0.82%
PTGX -1.39%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 1.63%
QLGN -8.10%
QNCX 5.70%
QNRX 0.37%
QSI -11.97%
QSIAW -3.13%
QTTB -1.83%
QURE -0.84%
RAIN -1.63%
RANI 6.42%
RAPT -3.57%
RARE 1.33%
RCKT -7.59%
REGN -0.26%
RENB -3.42%
REPL -2.83%
RETA 0.02%
REUN -0.89%
REVB -1.42%
REVBU 3.46%
REVBW 4.38%
RGLS -5.37%
RGNX -5.93%
RIGL -3.29%
RLAY -3.78%
RLMD 0.33%
RLYB -0.67%
RNA 0.23%
RNAC -5.94%
RNAZ -0.96%
RNXT 1.88%
ROIV -1.99%
ROIVW 4.56%
RPHM -0.31%
RPRX 0.24%
RPTX -2.51%
RUBY 2.70%
RVLP -32.05%
RVMD -0.88%
RVMDW -30.00%
RVNC 2.34%
RVPH -1.19%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.40%
RYTM -6.34%
RYZB 0.02%
RZLT 1.55%
SABS -1.37%
SABSW -11.81%
SAGE 2.02%
SANA -3.79%
SAVA -0.60%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH 2.40%
SCPS 0.00%
SEEL -4.74%
SEER 0.59%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 0.23%
SGMT -2.16%
SGTX -2.56%
SIOX 22.63%
SLDB -6.74%
SLGL 2.97%
SLN -4.40%
SLNO -3.84%
SLRX 6.07%
SLS -2.14%
SMMT -2.60%
SNDX 1.51%
SNGX -2.66%
SNPX -3.84%
SONN -1.08%
SPPI -0.49%
SPRB 0.91%
SPRC -2.75%
SPRO 0.05%
SRNE -34.00%
SRPT -1.13%
SRRA 0.00%
SRRK -2.35%
SRZN -2.45%
STAB 0.00%
STOK -4.59%
STRO -2.85%
STSA 0.00%
STTK -1.55%
SURF -0.93%
SVRA -4.99%
SWTX 0.19%
SYBX -1.29%
SYRS -1.03%
TALS -0.73%
TARA -8.10%
TARS -0.56%
TBPH 0.60%
TCBP 2.47%
TCDA 0.00%
TCON 2.74%
TCRR 0.00%
TCRT 1.59%
TCRX 1.45%
TECH -0.11%
TENX -1.27%
TERN -7.45%
TFFP -5.33%
TGTX -3.18%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -2.59%
TNGX -2.59%
TNXP -6.19%
TNYA -5.43%
TPST 3.16%
TRDA -4.64%
TRVI 2.30%
TRVN 2.97%
TSHA -24.75%
TSVT -2.93%
TTNP -7.79%
TVTX 0.88%
TYRA -7.13%
UBX -0.71%
UNCY -3.90%
URGN -1.52%
UTHR -0.48%
VACC 11.36%
VALN -2.89%
VAXX 83.69%
VBIV 0.78%
VBLT -8.77%
VCEL -0.23%
VCNX 10.35%
VCYT -0.93%
VERA -3.86%
VERU -0.72%
VERV -2.87%
VIGL 7.26%
VINC 2.96%
VIR 0.65%
VIRI -1.61%
VIRX 2.40%
VKTX -1.26%
VLON -13.04%
VNDA -2.61%
VOR -2.02%
VRCA 0.00%
VRDN -4.23%
VRNA -1.40%
VRPX 0.38%
VRTX 0.29%
VSTM -1.19%
VTGN -1.05%
VTVT -2.97%
VTYX -1.26%
VXRT -3.72%
VYGR -0.77%
VYNE -4.60%
VYNT 7.78%
WINT -3.24%
WVE -4.19%
XBIO 0.93%
XBIT -1.04%
XCUR 3.58%
XENE -2.86%
XERS 2.14%
XFOR 2.86%
XLO 4.54%
XLRN 0.00%
XNCR 0.47%
XOMA -2.94%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.96%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.89%
ZNTL -0.69%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2022-02-10 Aberman Zami Buy 80 616 Common Stock
2021-05-26 Clover Wolf Capital - Limited Partnership Sell 122 663 Common Stock
2021-05-26 Clover Wolf Capital - Limited Partnership Sell 22 015 Common Stock
2021-05-27 Clover Wolf Capital - Limited Partnership Sell 71 775 Common stock
2021-05-27 Clover Wolf Capital - Limited Partnership Sell 24 110 Common stock
INSIDER POWER
0.00
Last 98 transactions
Buy: 11 245 290 | Sell: 1 084 851

Volume Correlation

Long: 0.39 (neutral)
Short: -0.82 (strong negative)
Signal:(32.85) Neutral

Pluristem Therapeutics Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pluristem Therapeutics Correlation - Currency/Commodity

The country flag -0.50
( neutral )
The country flag -0.12
( neutral )
The country flag 0.00
( neutral )
The country flag -0.36
( neutral )
The country flag 0.00
( neutral )
The country flag 0.85
( strong )

Pluristem Therapeutics Financials

Annual 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.770
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.770
FY 2020
Revenue: $23 000.00
Gross Profit: $23 000.00 (100.00 %)
EPS: $-1.600
FY 2019
Revenue: $54 000.00
Gross Profit: $52 000.00 (96.30 %)
EPS: $-2.90

Financial Reports:

No articles found.

Pluristem Therapeutics Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Pluristem Therapeutics

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA\'s Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 3.2428040504456 seconds
Number of API calls: 3
Number of DB calls: 9